April 2011 Archives

April 19, 2011

Topamax Recall After Reports Of Unusual Odors

Johnson & Johnson has issued a Topamax recall after receiving complaints about an unusual odor linked to a byproduct from a chemical used in treating wood. Sources believe the contamination may have occurred as a result of the way medication is shipped and stored.

Topamax has recently come under fire after the FDA issued warnings of an increased risk of cleft lips and cleft palates in infants of mothers who take Topamax (topiramate) during pregnancy.

The FDA has given the Topamax a pregnancy risk rating of D, indicating positive evidence of human fetal risk and birth defects.

Topamax has also been linked to eye disorders such as blurred vision, acute myopia and secondary angle closure glaucoma.

Continue reading "Topamax Recall After Reports Of Unusual Odors" »

April 12, 2011

Senate To Begin Investigation Of DePuy Hip Safety

This week the U.S Senate will begin its probe into medical device recalls and the connection between the massive DePuy Hip Replacement recall and the FDA's role in "protecting patient safety as part of the medical device approval process."

The DePuy Hip was recalled after numerous reports of metal shards breaking off the hip replacement and lodging themselves in patients' bodies. Although in many cases revision surgeries can correct the problem, many times permanent bone and tissue damage will occur.

If you have been fitted with a DePuy Hip, contact a knowledgeable DePuy ASR Hip System recall attorney. It is important to speak with an attorney to review your medical records and reports in order to determine the next best steps on your behalf.

Lawsuits have been filed in New Mexico and across the county accusing DePuy of manufacturing a defective product, failing to adequately warn doctors and patients of the potential for harm, and negligence.

Continue reading "Senate To Begin Investigation Of DePuy Hip Safety" »

April 5, 2011

Zimmer NexGen Knee Recall Urged Due To Component Problems

Several physicians are urging a Zimmer NexGen Knee recall as the result of serious problems and component failures in the knee, requiring additional surgeries. The FDA has recalled some of the components following several lawsuits concerning the Zimmer NexGen CR-Flex knee failure rate. In fact, a prominent consultant for Zimmer recently went public stating that the Zimmer NexGen knee has significant problems and warned against its use.

If you have undergone knee replacement surgery, contact a Zimmer NexGen Knee attorney for more information regarding the Zimmer NexGen knees and its safety risks.

Continue reading "Zimmer NexGen Knee Recall Urged Due To Component Problems" »